who reports todayUS earnings, drawn as flowsMy portfolio

← Who reports today · Health Care

IDXX · Q2 2026

Archived report (Q2 2026). Latest deep dive →

US GAAP, Q2 2026 · quarter ended 06/30/2026 · released Aug 4

The quarter in brief

Revenue grew 9.7% y⁠/⁠y to $1.22B, operating margin 35.0% vs 33.6%, net income $338M (+15.1% y⁠/⁠y).

Net income attributable to stockholders

$338M

up 15.1% y/y

Revenue

$1,217M

up 9.7% y/y

Income from operations

$426M

up 14.1% y/y

Gross profit

$779M

up 12.1% y/y

All figures in $M.

Sankey diagram of IDXX earnings report for Q2 2026: revenue, costs and profitRevenue$1,217 · +9.7%Cost of revenue$437 · +5.5%Gross profit$779 · +12.1%64.0% marginSales andmarketing$171 · +6.3%General andadministrative$117 · +18.4%Research anddevelopment$65.4 · +5.7%Income fromoperations$426 · +14.1%35.0% marginNon-operatingincome (expense),net$8.3 · −22.0%Income beforeprovision forincome taxes$417 · +15.1%Provision for income taxes$78.8 · +15.3%18.9% effective rateNet income attributable tostockholders$338 · +15.1%$4.27/sh · 27.8% margin
Sankey diagram of IDXX earnings report for Q2 2026: revenue, costs and profit
Line itemAmount and change
Revenue$1,217 · +9.7%
Cost of revenue$437 · +5.5%
Gross profit$779 · +12.1% · 64.0% margin
Sales and marketing$171 · +6.3%
General and administrative$117 · +18.4%
Research and development$65.4 · +5.7%
Income from operations$426 · +14.1% · 35.0% margin
Non-operating income (expense), net$8.3 · −22.0%
Income before provision for income taxes$417 · +15.1%
Provision for income taxes$78.8 · +15.3% · 18.9% effective rate
Net income attributable to stockholders$338 · +15.1% · $4.27/sh · 27.8% margin

Verdict: revenue grew 9.7% y/y to $1.22B, operating margin 35.0% vs 33.6%, net income $338M (+15.1% y/y).

Source and notation

Source: IDEXX Laboratories press release, 8-K EX-99.1 of 08/04/2026 (SEC EDGAR). Every figure was matched against the income statement in the release and checked against SEC XBRL.

Open as an image: IDXX, Q2 2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0

Cite / embed this chart

Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).

Credit line
Chart: “IDXX Q2 2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/idxx/q2-2026. Licensed under CC BY 4.0.
HTML: image with link and credit
<figure>
  <a href="https://whoreportstoday.com/t/idxx/q2-2026"><img src="https://whoreportstoday.com/t/idxx/q2-2026/sankey.png" alt="IDXX Q2 2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a>
  <figcaption>Source: <a href="https://whoreportstoday.com/t/idxx/q2-2026">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption>
</figure>
Direct link to the image (PNG)
https://whoreportstoday.com/t/idxx/q2-2026/sankey.png
Link for your article text
<a href="https://whoreportstoday.com/t/idxx/q2-2026">IDXX Q2 2026 earnings chart (Who Reports Today)</a>

This is an archived report: the image at this link won’t change. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.

IDXX — an animal-health diagnostics company that makes analyzers, rapid tests and software for veterinary clinics and runs reference laboratories, and also sells water and livestock testing products.

Its reportable segments are the Companion Animal Group, Water quality products, and Livestock, Poultry and Dairy; human point-of-care diagnostics are reported as Other. · Source: annual report (Form 10-K, SEC)

More reports: ILMN · Q3 2026 · INCY · Q2 2026 · IQV · Q3 2026 · ISRG · Q3 2026 · JNJ · Q3 2026 · LH · Q3 2026 · LLY · Q3 2026 · MCK · Q1 FY2027 · MDT · Q1 2027 · MRK · Q3 2026 · all reports

Company reports

Q3 2026latest breakdownIDEXX grew Q3 2026 revenue 9.9% y/y to $1,214 million, and operating income rose 13.4% to $402.3 million as operating…
Q2 2026Revenue grew 9.7% y/y to $1.22B, operating margin 35.0% vs 33.6%, net income $338M (+15.1% y/y).

Cookies the site needs and, with your consent, Google Analytics — privacy policy